A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility.
Lair
L
Zambon
Helen N
HN
Honma
Gustavo J
GJ
Lourenço
Ivete A B
IA
Saad
Ricardo K
RK
Mussi
Carmen S P
CS
Lima
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D004273:DNA, Neoplasm / Q000235:genetics*; D043169:Endostatins / Q000235:genetics* / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000235:genetics / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D043169:Endostatins